Skip to main content
. 2023 Apr 18;40(6):2741–2751. doi: 10.1007/s12325-023-02503-3

Fig. 2.

Fig. 2

Group weighted estimates for survival percentage at 10 and 20 years for patients in the placebo arm of DAPA-CKD compared to KM survival estimates from DAPA-CKD placebo and active arms. Trial data and highest and lowest literature KM estimates (solid portions of lines) were extrapolated (dashed portions of lines) using SMRs using age- and sex-adjusted general-population life tables. KM Kaplan–Meier, SMR standard mortality ratio